The Bucharest Stock Exchange (BVB) is holding today an event for the listing of new Fidelis government bonds issued by the Romanian Ministry of Finance.

The public offering, running June 18 to 28, 2024, included five issues, two euro-denominated and three denominated in lei, the local currency, one of which was dedicated to blood donors.

The event will be attended by BVB Chairman Radu Hanga; Financial Supervisory Authority official Ovidiu Petru; senior official with the Ministry of Finance Alin Andries; Director General of the State Treasury Stefan Nanu; Director of Equity Trading, Alpha Bank Romania, Emilian Dobran, and BVB CEO Adrian Tanase.

The Ministry of Finance released on June 18 the third edition of this year’s Fidelis Government Bond Programme, with blood donors being the main beneficiaries of the best interest rate.

After a successful H1 2024, when, under the blood donation campaign of the Fidelis Programme, more than 10,000 lives were saved through investments of over RON 400 million from 3,031 donors, the Ministry of Finance decided to increase the frequency of such issues from four to six per year.

The bonds designed for blood donors belong to the government bonds denominated in lei, with a maturity of one year, paying an interest rate of 7%, the highest offered in this edition.

The third edition of Fidelis also contained the usual issues, namely: leu-denominated government bonds, with maturities of one year and three years and annual interest rates of 6% and 6.85%, respectively, and euro-denominated government bonds, with maturities of one year and five years and annual interest rates of 45 and 5%, respectively.

The nominal value of a government bond was RON 100 in the issue denominated in lei and EUR 100 for the issue denominated in euros, and the minimum subscription threshold was RON 5,000 and EUR 1,000, respectively.

According to the Ministry of Finance, holders of matured Fidelis government bonds launched in the previous sessions were able to reinvest the unraised funds at maturity, by subscribing to this new issue.

AGERPRES